Literature DB >> 24461297

Rat intestinal sucrase inhibition of constituents from the roots of Rosa rugosa Thunb.

Nguyen Phuong Thao1, Bui Thi Thuy Luyen1, Bui Huu Tai2, Seo Young Yang3, Sung Hoo Jo4, Nguyen Xuan Cuong2, Nguyen Hoai Nam2, Young In Kwon4, Chau Van Minh2, Young Ho Kim5.   

Abstract

A new octanordammarane triterpene, 3β,15α-dihydroxymansumbinol (1) and a novel A-ring contracted oleanane triterpenoid, 2-formyl-(A)1-19α-hydroxy-1-norolean-2,12-dien-28-oic acid (2) were isolated from the roots extract of Rosa rugosa along with fifteen known compounds (3-17). Their structures were elucidated by extensive spectroscopic analysis, including 1D and 2D NMR, and FTICRMS. The MeOH extract, as well as CH2Cl2 and EtOAc fractions at a concentration of 0.5mg/mL showed potent sucrase inhibitory activity, with inhibition percentage values of 84.67±5.37%, 87.50±2.78%, and 81.91±2.90%, respectively. In addition, compounds 7-13 (1.0 mM) showed potent sucrase inhibitory activity (61.88±3.19% to 84.70±3.07% inhibition), which was comparable to that of the positive control, acarbose, with an inhibition percentage value of 50.96±2.97%. Compounds 1, 2, 4, and 14-17 showed moderate and/or weak inhibitory activities at the same concentration. The α-glucosidase inhibitory activities of the extracts and purified compounds may provide a novel opportunity to develop a new class of antidiabetic agents. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  A-ring contracted oleanane triterpenoid; Rosa rugosa; Rosaceae; Rosanol A; Rusaic acid B; α-Glucosidase inhibition

Mesh:

Substances:

Year:  2014        PMID: 24461297     DOI: 10.1016/j.bmcl.2013.12.098

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Determination of the volatile and polyphenol constituents and the antimicrobial, antioxidant, and tyrosinase inhibitory activities of the bioactive compounds from the by-product of Rosa rugosa Thunb. var. plena Regal tea.

Authors:  Guixing Ren; Peng Xue; Xiaoyan Sun; Gang Zhao
Journal:  BMC Complement Altern Med       Date:  2018-11-20       Impact factor: 3.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.